Stay updated on Antimicrobial Immunomodulation in PSC Clinical Trial
Sign up to get notified when there's something new on the Antimicrobial Immunomodulation in PSC Clinical Trial page.

Latest updates to the Antimicrobial Immunomodulation in PSC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedIntroduces a new Locations section and specifies California (Palo Alto) as the study site. The footer revision updates from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedPublications section now includes clarifications that some publications are provided voluntarily and may not be about the study. It also notes that entries are automatically filled from PubMed, with a Revision: v3.3.2 tag.SummaryDifference0.2%

- Check50 days agoChange DetectedThe government funding/operating status notice has been removed from the page; all trial details, eligibility criteria, locations, and contacts remain unchanged.SummaryDifference0.4%

- Check71 days agoChange DetectedThe new screenshot shows UI/layout updates (header and spacing) with no changes to core study details, eligibility criteria, or outcome measures.SummaryDifference0.4%

- Check93 days agoChange DetectedMajor update: version bumped to v3.2.0 and a prominent operating-status notice added (government funding lapse). The previous version v3.1.0 was removed.SummaryDifference4%

- Check100 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Antimicrobial Immunomodulation in PSC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antimicrobial Immunomodulation in PSC Clinical Trial page.